Reaction

Ocular Icterus reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 4,274 reports · 110 co-occurring drugs

As of the last recalculation, Ocular Icterus appears in 4,274 FAERS reports alongside 110 co-occurring drug terms. The strongest observed disproportionality signal is ATAZANAVIR (PRR 34.7).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Atazanavir	100	34.7	34.9
Regorafenib	39	16.5	16.6
Avapritinib	35	14.2	14.2
Rifampicin	29	14.0	14.1
Ritonavir	82	13.9	14.0
Abacavir Sulfate	27	13.6	13.6
Dolutegravir Sodium	21	11.4	11.4
Deferasirox	61	11.4	11.4
Lopinavir And Ritonavir	31	11.2	11.2
Glecaprevir And Pibrentasvir	25	11.1	11.2
Isoniazid	33	10.0	10.0
Pyrazinamide	19	9.9	9.9
Ritonavir 100 Mg	30	9.8	9.9
Sorafenib	39	9.2	9.2
Eculizumab	94	8.6	8.6
Ursosiol	32	8.1	8.1
Ursodiol	35	7.9	7.9
Epoetin Alfa	18	7.4	7.4
Diroximel Fumarate	18	7.4	7.4
Entecavir	16	6.7	6.7
Mercaptopurine	23	6.5	6.5
Ribavirin	83	6.4	6.4
Tenofovir Disoproxil Fumarate Tablets	11	6.2	6.2
Emtricitabine And Tenofovir Disoproxil Fumarate	56	6.0	6.1
Lamivudine Oral	31	6.0	6.0
Lamivudine	37	5.9	5.9
Methimazole	9	5.6	5.6
Zidovudine	15	5.5	5.5
Rifampin	16	5.4	5.4
Piperacillin And Tazobactam	14	5.3	5.3
Raltegravir	18	5.3	5.3
Goserelin	14	5.1	5.1
Nitrofurantoin	17	5.0	5.0
Dapsone	11	5.0	5.0
Minocycline	12	5.0	5.0
Daspone	10	5.0	5.0
Dapsone Gel, 5%	10	5.0	5.0
Nitrofurantoin (Monohydrate/Macrocrystals)	17	5.0	5.0
Insulin Glulisine	10	4.8	4.8
Tenofovir Disoproxil Fumarate	32	4.7	4.7
Eltrombopag Olamine	22	4.7	4.7
Peginterferon Alfa-2A	50	4.5	4.5
Piperacillin Sodium And Tazobactam Sodium	18	4.5	4.5
Ceftriaxone	30	4.5	4.5
Ketoprofen	12	4.5	4.5
Lapatinib	14	4.4	4.4
Ravulizumab	12	4.3	4.3
Nevirapine	8	4.3	4.3
Hydroxyurea	18	4.2	4.2
Orlistat	22	4.2	4.2
Voxelotor	19	4.1	4.1
Sunitinib Malate	33	4.1	4.1
Clarithromycin	28	4.0	4.0
Pegaspargase	10	4.0	4.0
Sofosbuvir	16	4.0	4.0
Ceftriaxone Sodium	31	4.0	4.0
Calcitriol Capsules 0.25 Mcg	16	3.9	3.9
Calcitriol Capsules 0.5 Mcg	16	3.9	3.9
Ribociclib	25	3.9	3.9
Calcitriol	16	3.9	3.9
Amoxicillin And Clavulanate Potassium	21	3.8	3.8
Letrozole Tablets	36	3.7	3.7
Cholestyramine	9	3.6	3.6
Fenofibrate	26	3.6	3.6
Iron Sucrose	7	3.6	3.6
Rifaximin	15	3.5	3.5
Naltrexone	22	3.5	3.5
Letrozole	43	3.4	3.4
Fulvestrant	23	3.4	3.4
Liothyronine Sodium	6	3.4	3.4
Macitentan	47	3.3	3.3
Imatinib Mesylate	19	3.3	3.3
Piperacillin Sodium,Tazobactam Sodium	18	3.3	3.3
Interferon Beta-1B	13	3.3	3.3
Terbinafine Hydrochloride	6	3.3	3.3
Darunavir	10	3.2	3.2
Bosentan	33	3.2	3.2
Meropenem	21	3.2	3.2
Elexacaftor, Tezacaftor, And Ivacaftor	8	3.1	3.1
Ledipasvir And Sofosbuvir	12	3.0	3.0
Posaconazole	10	3.0	3.0
Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide	6	2.9	2.9
Dimethyl Fumarate	72	2.9	2.9
Atomoxetine Hydrochloride	14	2.9	2.9
Ranolazine	6	2.8	2.8
Vincristine Sulfate	16	2.7	2.7
Velpatasvir And Sofosbuvir	7	2.7	2.7
Amlodipine Besylate And Valsartan	6	2.6	2.6
Capecitabine	48	2.6	2.6
Pazopanib Hydrochloride	13	2.3	2.3
Dalfampridine	33	2.2	2.3
Peginterferon Beta-1A	6	2.2	2.2
Paricalcitol	6	2.1	2.1
Bimatoprost	12	2.0	2.0
Riociguat	13	1.9	1.9
Gemcitabine	15	1.9	1.9
Buprenorphine Hydrochloride, Naloxone Hydrochloride	9	1.8	1.8
Sevelamer Carbonate	4	1.7	1.7
Vemurafenib	4	1.6	1.6
Teriflunomide	15	1.6	1.6
Nirmatrelvir And Ritonavir	15	1.4	1.4
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate	5	1.3	1.3
Dornase Alfa	5	1.2	1.2
Ambrisentan	31	1.2	1.2
Drospirenone And Ethinyl Estradiol	10	1.1	1.1
Pirfenidone	9	1.1	1.1
Levonorgestrel	35	0.8	0.8
Cinacalcet Hydrochloride	8	0.8	0.8
Tirzepatide	27	0.8	0.8
Etonogestrel	6	0.6	0.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.